High-tech therapies such as gene, cell, and orphan drug therapies are becoming more popular, and that these therapies can be very costly.

Self-insured employers are seeing an increase in high-cost health claims in the area of respiratory illness and mental health, a new report has found. The 2021 Accident and Health Market Report, released by stop-loss insurer QBE compared high-dollar claims from the months preceding the COVID-19 pandemic to costs from the early months of 2021. It found that while the top area of high-dollar claims, cancer treatment, moderated somewhat, other high-cost claims in the areas of respiratory illness and mental health saw significant increases.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Cost-Containment
Employer-Paid